-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicus Pharma Ltd. Seeks FDA Fast-Track Approval for Innovative Skin Cancer Treatment with Dissolvable Doxorubicin Microneedle Arrays

Reuters·07/08/2025 11:31:31

Please log in to view news